Therefore, semaglutide appears to be a useful treatment option for patients with type 2 diabetes who also have impaired renal function, including those with ESRD undergoing hemodialysis
If you are already on weight loss medication, for example, if you are using Wegovy or Mounjaro (tirzepatide) in the form of an injection, you may be able to switch
Importantly, the FDA labeling cautions against using semaglutide in patients with severe gastrointestinal disease, including severe gastroparesis
Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial The Lancet Diabetes & Endocrinology, 2025
[11] - Women with kidney disease (CKD stage 3 or worse) kidneys are how potassium leaves the body